Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Baxter International (NY: BAX )

38.96 +0.14 (+0.36%)
Official Closing Price Updated: 7:00 PM EDT, Sep 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,154,937
Open 38.82
Bid (Size) 37.69 (1)
Ask (Size) 39.81 (1)
Prev. Close 38.82
Today's Range 38.41 - 39.48
52wk Range 31.01 - 44.01
Shares Outstanding 499,910,255
Dividend Yield 2.98%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Medtronic Recalls Some Video Laryngoscopes Due To Increased Risk For Battery Overheat, Explosion
Medtronic recalls devices over battery risks that could lead to explosions and updates usage instructions. 
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Baxter to Present at 2024 Wells Fargo Healthcare Conference
From Baxter International Inc.
Via Business Wire

Performance

YTD
+0.28%
+0.28%
1 Month
+4.12%
+4.12%
3 Month
+18.46%
+18.46%
6 Month
-10.40%
-10.40%
1 Year
+0.75%
+0.75%

More News

Read More
Rivian, Chipotle Mexican And Sirius XM Are Among Top 10 Large Cap Losers Last Week (Aug 11-Aug 17): Are The Others In Your Portfolio?
Via Benzinga
Baxter Tumbles On $3.8 Billion Kidney Deal — Why Investors Expected More
Via Investor's Business Daily
The Latest Analyst Ratings For Baxter Intl
Via Benzinga
Assessing Baxter Intl: Insights From 4 Financial Analysts
Via Benzinga
How Is The Market Feeling About Baxter Intl?
Via Benzinga
Unveiling 5 Analyst Insights On Baxter Intl
Via Benzinga
Baxter Seals $3.8B Deal With Carlyle For Its Kidney Care Segment
Via Benzinga
Baxter Announces Definitive Agreement to Divest Its Vantive Kidney Care Segment to Carlyle for $3.8 Billion
From Baxter International Inc.
Via Business Wire
BAX Stock Earnings: Baxter Intl Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Baxter Lifts Annual Outlook After Strong Q2 Beat, Medical Devices Sales
Via Benzinga
Baxter Reports Second-Quarter 2024 Results
From Baxter International Inc.
Via Business Wire
3 Contrarian Stock Picks to Buy Against the Market Consensus
Via InvestorPlace
Carlyle's $4B Purchase Of Baxter's Kidney Division Backed By Ares And HPS Financing
Via Benzinga
Baxter to Host Second-Quarter 2024 Financial Results Conference Call for Investors
From Baxter International Inc.
Via Business Wire
Baxter Declares Quarterly Dividend
From Baxter International Inc.
Via Business Wire
AutoNation, Baxter International And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Baxter publishes annual corporate responsibility report, highlighting continued focus on creating lasting impact
From Baxter International Inc.
Via Business Wire
3 Bargain Bin Stocks with Millionaire-Maker Potential
Via InvestorPlace
Carlyle Eyes $4B Acquisition Of Baxter's Kidney-Care Unit Vantive: Report
Via Benzinga
“Cash Flow Is The Name Of The Game” Stock Market
Via Talk Markets
Topics Economy
Exposures Interest Rates
Baxter to Present at Goldman Sachs 45th Annual Global Healthcare Conference
From Baxter International Inc.
Via Business Wire
7 Deeply Undervalued Stocks to Buy Now or Regret Later
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.